US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CervoMed

8.78

+0.14001.62%

Post-market: 8.60-0.1800-2.05%19:47 EDT

Volume:83.64K

Turnover:736.60K

Market Cap:76.41M

PE:-4.09

High:8.98

Open:8.60

Low:8.60

Close:8.64

Loading ...

Overview Company News Filings

CervoMed Inc. Unveils Presentation on Pioneering Oral Drug Neflamapimod for Dementia with Lewy Bodies

CervoMed’s Strategic Advancements and Market Opportunities Drive Buy Rating

CervoMed Inc. CFO William Robert Elder Reports Acquisition of Common Shares

Chardan Adjusts Price Target on CervoMed to $15 From $14, Maintains Buy Rating

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: CervoMed (CRVO) and Biohaven Ltd. (BHVN)

CervoMed (CRVO) Receives a Buy from Roth MKM

CervoMed Inc. Reports Q1 2025 Financial Results

CervoMed Is Maintained at Buy by Chardan Capital

CervoMed Announces $50M Sales Agreement with Leerink

CervoMed Inc reports results for the quarter ended March 31 - Earnings Summary

BRIEF-Cervomed Co Enters Sales Agreement With Leerink Partners LLC

CervoMed Inc - Co Enters Sales Agreement With Leerink Partners Llc

THOMSON REUTERS

CervoMed - Pursuant to Sales Agreement, Co May Offer & Sell, From Time to Time, Shares Having Aggregate Offering Price up to $50 Mln

THOMSON REUTERS

CervoMed Q1 EPS $(0.56) Beats $(0.66) Estimate, Sales $1.92M Beat $1.72M Estimate

Press Release: CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates

CervoMed Inc expected to post a loss of 66 cents a share - Earnings Preview

CervoMed participates in a meeting with Roth MKM

CervoMed’s Promising Data and Phase 3 Prospects Boost Buy Rating

CervoMed Reports Positive Phase 2b Trial Results

Calendar of U.S. Earnings Expected in the Week Ahead

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CRVO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":8.78,"timestamp":1747425600000,"preClose":8.64,"halted":0,"volume":83636,"hourTrading":{"tag":"盘后","latestPrice":8.6,"preClose":8.78,"latestTime":"19:47 EDT","volume":1758,"amount":15350.065,"timestamp":1747439249849},"delay":0,"floatShares":5797499,"shares":8702719,"eps":-2.144491,"marketStatus":"Market Closed","change":0.14,"latestTime":"05-16 16:00:00 EDT","open":8.6,"high":8.98,"low":8.6,"amount":736599.39738,"amplitude":0.043981,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.144491,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":8.64,"preHourTrading":{"tag":"盘前","latestPrice":8.67,"preClose":8.64,"latestTime":"09:13 EDT","volume":22,"amount":189.455002,"timestamp":1747401212460},"postHourTrading":{"tag":"盘后","latestPrice":8.6,"preClose":8.78,"latestTime":"19:47 EDT","volume":1758,"amount":15350.065,"timestamp":1747439249849},"volumeRatio":0.3470131541977544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","floatShares":5797499,"roa":"-56.19%","roe":"-93.42%","lyrEps":-2.017884,"volumeRatio":0.3470131541977544,"shares":8702719,"dividePrice":0,"high":8.98,"amplitude":0.043981,"preClose":8.64,"low":8.6,"week52Low":1.8,"pbRate":"2.21","psRate":"8.21","week52High":24.795,"institutionHeld":0,"latestPrice":8.78,"eps":-2.144491,"divideRate":0,"volume":83636,"delay":0,"ttmEps":-2.144491,"open":8.6,"prevYearClose":2.34,"prevWeekClose":8.49,"prevMonthClose":9.06,"prevQuarterClose":9.15,"fiveDayClose":8.49,"twentyDayClose":9.8,"sixtyDayClose":2.325},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRVO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536401473","title":"CervoMed Inc. Unveils Presentation on Pioneering Oral Drug Neflamapimod for Dementia with Lewy Bodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2536401473","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536401473?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:13","pubTimestamp":1747426422,"startTime":"0","endTime":"0","summary":"CervoMed Inc., a late clinical stage CNS company, presented its corporate overview, highlighting the development of neflamapimod, an oral drug targeting early-stage neurodegenerative diseases. Specifically focusing on Dementia with Lewy bodies , the company emphasizes a significant commercial opportunity with a potential $5B US market. Neflamapimod, licensed from Vertex Pharmaceuticals, aims to address synaptic dysfunction in age-related neurological disorders and has received Fast Track designation from the FDA. CervoMed, which began trading on NASDAQ in August 2023, is headquartered in Boston, MA, and operates with a team of 15 full-time employees. The company has an experienced leadership team and has achieved proof-of-concept in DLB through successful phase 2 trials, with plans for a single phase 3 study to support NDA submission. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL7GnV3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU0079474960.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU1069344957.HKD","LU2362540622.SGD","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU2456880835.USD","SG9999013999.USD","BK4567","LU1430594728.SGD","LU2362541513.USD","LU0823416689.USD","LU0109394709.USD","LU0289739699.SGD","SGXZ57979304.SGD","LU2236285917.USD","IE00BJT1NW94.SGD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU2417539215.USD","BK4532","IE00BJJMRZ35.SGD","IE0002270589.USD","IE00BZ9MQY76.HKD","BK4588","LU1585245621.USD","BK4533","LU2362541273.HKD","LU0320765992.SGD","BK4139","SG9999001176.USD","LU0058720904.USD","LU1035775433.USD","LU0256863811.USD","LU0061475181.USD","IE00B19Z9Z06.USD","LU0417517546.SGD","IE0002141913.USD","IE00B894F039.SGD","IE00B19Z3B42.SGD","LU0234570918.USD","LU2462157665.USD","IE0009355771.USD","LU2324357040.USD","VRTX","LU1093756325.SGD","CRVO","LU1093756168.USD"],"gpt_icon":0},{"id":"2536348018","title":"CervoMed’s Strategic Advancements and Market Opportunities Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2536348018","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536348018?lang=en_us&edition=fundamental","pubTime":"2025-05-17 00:25","pubTimestamp":1747412729,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on CervoMed (CRVO – Research Report), with a price target of $15.0...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cervomeds-strategic-advancements-and-market-opportunities-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cervomeds-strategic-advancements-and-market-opportunities-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO"],"gpt_icon":0},{"id":"2535900758","title":"CervoMed Inc. CFO William Robert Elder Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2535900758","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535900758?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:12","pubTimestamp":1747253547,"startTime":"0","endTime":"0","summary":"William Robert Elder, the CFO, GC & Secretary of CervoMed Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL8BhQBV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2535377323","title":"Chardan Adjusts Price Target on CervoMed to $15 From $14, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535377323","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535377323?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:53","pubTimestamp":1747140830,"startTime":"0","endTime":"0","summary":"CervoMed (CRVO) has an average rating of buy and mean price target of $16, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and res","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRVO"],"gpt_icon":0},{"id":"2535725028","title":"Analysts Offer Insights on Healthcare Companies: CervoMed (CRVO) and Biohaven Ltd. (BHVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535725028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535725028?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:01","pubTimestamp":1747134070,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CervoMed (CRVO – Research Report) and Biohaven Ltd. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cervomed-crvo-and-biohaven-ltd-bhvn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cervomed-crvo-and-biohaven-ltd-bhvn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","BK4137","CRVO","BK4139","HCSG","BHVN","LU1093756168.USD"],"gpt_icon":0},{"id":"2535772528","title":"CervoMed (CRVO) Receives a Buy from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2535772528","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535772528?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:00","pubTimestamp":1747134031,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on CervoMed (CRVO – Research Report) today and set a price target of $20.00. The com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cervomed-crvo-receives-a-buy-from-roth-mkm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cervomed-crvo-receives-a-buy-from-roth-mkm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2535225769","title":"CervoMed Inc. Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535225769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535225769?lang=en_us&edition=fundamental","pubTime":"2025-05-13 12:21","pubTimestamp":1747110108,"startTime":"0","endTime":"0","summary":"Cervomed Inc. ( ($CRVO) ) has released its Q1 earnings. Here is a breakdown of the information Cervomed Inc. presented to its investors. CervoMed I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-inc-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-inc-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2535733553","title":"CervoMed Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2535733553","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535733553?lang=en_us&edition=fundamental","pubTime":"2025-05-13 06:14","pubTimestamp":1747088040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRVO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2025 18:14 ET (22:14 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"gpt_icon":0},{"id":"2535780651","title":"CervoMed Announces $50M Sales Agreement with Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2535780651","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535780651?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:13","pubTimestamp":1747084432,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) has shared an announcement. On May 12, 2025, CervoMed Inc. announced a sales agreement with Leerink Partners LLC to offer and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-announces-50m-sales-agreement-with-leerink?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-announces-50m-sales-agreement-with-leerink?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO"],"gpt_icon":0},{"id":"2535873847","title":"CervoMed Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535873847","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535873847?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:00","pubTimestamp":1747083645,"startTime":"0","endTime":"0","summary":"CervoMed Inc reports results for the quarter ended March 31 - Earnings SummaryCervoMed Inc CRVO.OQ reported a quarterly adjusted loss of 56 cents per share for the quarter ended March 31, lower than t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL8N3RK2PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"gpt_icon":0},{"id":"2535782110","title":"BRIEF-Cervomed Co Enters Sales Agreement With Leerink Partners LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2535782110","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535782110?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:51","pubTimestamp":1747083064,"startTime":"0","endTime":"0","summary":"BRIEF-Cervomed Co Enters Sales Agreement With Leerink Partners LLCMay 12  - CervoMed Inc CRVO.O:CERVOMED INC - CO ENTERS SALES AGREEMENT WITH LEERINK PARTNERS LLCCERVOMED - PURSUANT TO SALES AGREEMENT, CO MAY OFFER & SELL, FROM TIME TO TIME, SHARES HAVING AGGREGATE OFFERING PRICE UP TO $50 MILLIONFurther company coverage: CRVO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nFWN3RK2ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"gpt_icon":0},{"id":"2535782648","title":"CervoMed Inc - Co Enters Sales Agreement With Leerink Partners Llc","url":"https://stock-news.laohu8.com/highlight/detail?id=2535782648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535782648?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:47","pubTimestamp":1747082861,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nFWN3RK2ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2535192782","title":"CervoMed - Pursuant to Sales Agreement, Co May Offer & Sell, From Time to Time, Shares Having Aggregate Offering Price up to $50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2535192782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535192782?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:47","pubTimestamp":1747082861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nFWN3RK2ET:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2534224754","title":"CervoMed Q1 EPS $(0.56) Beats $(0.66) Estimate, Sales $1.92M Beat $1.72M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2534224754","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534224754?lang=en_us&edition=fundamental","pubTime":"2025-05-12 20:04","pubTimestamp":1747051478,"startTime":"0","endTime":"0","summary":"CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.66) by 15.15 percent. This is a 36.59 percent decrease over losses of $(0.41) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45345192/cervomed-q1-eps-0-56-beats-0-66-estimate-sales-1-92m-beat-1-72m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"gpt_icon":0},{"id":"2534122482","title":"Press Release: CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2534122482","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534122482?lang=en_us&edition=fundamental","pubTime":"2025-05-12 20:00","pubTimestamp":1747051200,"startTime":"0","endTime":"0","summary":"Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial, demonstrating proof-of-concept for neflamapimod as a potential treatment for dementia with Lewy bodies . Plan to initiate Phase 3 trial of neflamapimod in DLB in mid-2026 following meeting with regulatory authorities. Initiating separate Phase 2a trials to evaluate neflamapimod in patients with primary progressive aphasia and patients in the recovery phase after ischemic stroke. BOSTON, May 12, 2025  -- CervoMed Inc. , a clinical stage company focused on developing treatments for age-related neurologic disorders , today reported its financial results for the first quarter ended March 31, 2025.-- In March 2025, CervoMed reported positive 16-week results from the. extension phase of the RewinD-LB trial in which patients who were. administered a more recently manufactured batch of neflamapimod capsules. had higher plasma drug concentration levels and demonstrated improvements. on the primary outcom","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240877869.USD","BK4097","BK4099","03160","BK4585","LU0205194284.USD","LU0205193047.USD","BK4588","CRVO","LU0345774391.USD","LU0345774631.USD","DLB","PPA","BK4139","LU0348723411.USD","LU0240878834.USD","BK4555","TM","BK4604"],"gpt_icon":0},{"id":"2534549833","title":"CervoMed Inc  expected to post a loss of 66 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534549833","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534549833?lang=en_us&edition=fundamental","pubTime":"2025-05-10 08:26","pubTimestamp":1746836766,"startTime":"0","endTime":"0","summary":"CervoMed Inc  expected to post a loss of66cents a share - Earnings Preview CervoMed Inc CRVO.OQ CRVO.O is expected to show a fall in quarterly revenue when it reports  results on May 12 (estimated) fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250510:nL8N3RI020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"gpt_icon":0},{"id":"2532824791","title":"CervoMed participates in a meeting with Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2532824791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532824791?lang=en_us&edition=fundamental","pubTime":"2025-05-03 00:40","pubTimestamp":1746204050,"startTime":"0","endTime":"0","summary":"Meeting with Lawrence Sterling Honig, MD, PhD of Columbia University on May 7 hosted by Roth MKM. Published first on TheFly – the ultimate source f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cervomed-participates-in-a-meeting-with-roth-mkm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cervomed-participates-in-a-meeting-with-roth-mkm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2526457366","title":"CervoMed’s Promising Data and Phase 3 Prospects Boost Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2526457366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526457366?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:15","pubTimestamp":1744402516,"startTime":"0","endTime":"0","summary":"Soumit Roy, an analyst from JonesTrading, maintained the Buy rating on CervoMed (CRVO – Research Report). The associated price target remains the s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cervomeds-promising-data-and-phase-3-prospects-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cervomeds-promising-data-and-phase-3-prospects-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO"],"gpt_icon":0},{"id":"2525787079","title":"CervoMed Reports Positive Phase 2b Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2525787079","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525787079?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:30","pubTimestamp":1744057839,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) has provided an update. On April 2, 2025, CervoMed announced positive clinical results from the first sixteen weeks of the ope...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-reports-positive-phase-2b-trial-results-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-reports-positive-phase-2b-trial-results-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2525090470","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2525090470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525090470?lang=en_us&edition=fundamental","pubTime":"2025-04-07 18:00","pubTimestamp":1744020000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Dave & Buster's Ent                             4Q       .67       AMC. ·Kura Sushi USA                                  2Q      (.11)  4:05 PM. ·RPM Intl Inc.                                    3Q       .50   6:45 AM. ·Delta Air Lines Inc.                             1Q       .44   6:30 AM. ·Simply Gd Foods                                 2Q       .40   7:00 AM. ·Byrna Tech Inc.                                 1Q       .05   8:00 AM. ·Bank of N Y Mellon                                1Q      1.51   6:30 AM. ·Wells Fargo & Co                                 1Q      1.23   7:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNTY","IE00B1XK9C88.USD","LAKE","PGR","LU2242649171.HKD","LU2361044865.SGD","BSVN","LU0128525689.USD","BLK","BYRN","NRIX","FAST","BK4500","LU0795875169.SGD","LU1201861249.SGD","RPM","CALM","BK4113","STZ","LU0238689110.USD","PLAY","LOVE","LU2552382058.USD","LU1064131342.USD","LU1551013425.SGD","LU0787776722.HKD","PSMT","LU0320765489.SGD","LU1481011671.HKD","LEVI","IE00BN8TJ469.HKD","BK","SMPL","DAL","WAFD","LU0980610538.SGD","LU2106854487.HKD","LU0098860793.USD","BK4212","CARM","AMC","CRVO","KMX","NEOG","TBBB","LU2264538146.SGD","TLRY","MAMA","LU0052756011.USD","KRUS"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":107,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRVO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"CRVO","fiscalQuarterEnding":"2025/03","expectedEps":-0.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.56},{"market":"US","date":"2025-03-17","symbol":"CRVO","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2024-11-12","symbol":"CRVO","fiscalQuarterEnding":"2024/09","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.55},{"date":"2024-08-12","symbol":"CRVO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":-0.24,"defaultRemindTime":1723449600000,"name":null,"time":"Pre-Market","dateTimestamp":1723435200000,"actualEps":-0.27},{"date":"2024-05-15","symbol":"CRVO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715760000000,"name":null,"time":"Pre-Market","dateTimestamp":1715745600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRVO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.8571,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRVO","date":"2025-05-16","current":-4.027311,"percent":0.845209,"low":-119.682483,"twenty":-41.563272,"median":-22.735979,"eighty":-4.636974,"high":-1.31262,"avg":-27.26605,"sd":26.51476,"marketCap":75191492},"quantilePoints":[{"date":"2023-09-01","current":-5.788607,"twenty":-5.849231,"median":-5.813052,"eighty":-5.769051,"marketCap":33591560},{"date":"2023-09-08","current":-5.135433,"twenty":-5.817941,"median":-5.700604,"eighty":-4.975855,"marketCap":29801161},{"date":"2023-09-15","current":-4.791246,"twenty":-5.769051,"median":-5.182368,"eighty":-4.935961,"marketCap":27803825},{"date":"2023-09-22","current":-4.51746,"twenty":-5.708427,"median":-5.1589,"eighty":-4.822536,"marketCap":26215035},{"date":"2023-09-29","current":-4.66902,"twenty":-5.505043,"median":-5.045475,"eighty":-4.536234,"marketCap":27094543},{"date":"2023-10-06","current":-5.250814,"twenty":-5.262548,"median":-5.040586,"eighty":-4.536234,"marketCap":30470722},{"date":"2023-10-13","current":-6.893527,"twenty":-5.817941,"median":-5.065031,"eighty":-4.595684,"marketCap":40003462},{"date":"2023-10-20","current":-8.995809,"twenty":-6.690143,"median":-5.197035,"eighty":-4.691783,"marketCap":52203100},{"date":"2023-10-27","current":-9.201148,"twenty":-7.153624,"median":-5.22148,"eighty":-4.714546,"marketCap":53394692},{"date":"2023-11-03","current":-8.379791,"twenty":-8.309389,"median":-5.27037,"eighty":-4.77036,"marketCap":48628322},{"date":"2023-11-10","current":-9.709606,"twenty":-8.530373,"median":-5.764162,"eighty":-4.78929,"marketCap":56345302},{"date":"2023-11-17","current":-41.851906,"twenty":-9.287195,"median":-5.866832,"eighty":-4.791246,"marketCap":55950767},{"date":"2023-11-24","current":-43.761983,"twenty":-9.977525,"median":-6.385068,"eighty":-4.83818,"marketCap":58504301},{"date":"2023-12-01","current":-41.597229,"twenty":-22.855354,"median":-7.177091,"eighty":-4.969206,"marketCap":55610296},{"date":"2023-12-08","current":-37.39506,"twenty":-39.737313,"median":-7.68555,"eighty":-5.041564,"marketCap":49992521},{"date":"2023-12-15","current":-37.352614,"twenty":-39.16082,"median":-8.389569,"eighty":-5.054275,"marketCap":49935776},{"date":"2023-12-22","current":-28.736045,"twenty":-38.685423,"median":-8.477572,"eighty":-5.063075,"marketCap":38416500},{"date":"2023-12-29","current":-26.825968,"twenty":-38.401034,"median":-8.868694,"eighty":-5.079111,"marketCap":35862966},{"date":"2024-01-05","current":-39.899383,"twenty":-38.549596,"median":-9.044699,"eighty":-5.121353,"marketCap":53340488},{"date":"2024-01-12","current":-39.88198,"twenty":-39.488419,"median":-9.670494,"eighty":-5.172981,"marketCap":53317222},{"date":"2024-01-19","current":-38.625999,"twenty":-39.313626,"median":-10.04206,"eighty":-5.199968,"marketCap":51638132},{"date":"2024-01-26","current":-38.965567,"twenty":-39.313626,"median":-10.775414,"eighty":-5.223436,"marketCap":52092093},{"date":"2024-02-02","current":-34.593614,"twenty":-39.237223,"median":-27.727949,"eighty":-5.242992,"marketCap":46247338},{"date":"2024-02-09","current":-43.719537,"twenty":-39.237223,"median":-28.736045,"eighty":-5.262548,"marketCap":58447556},{"date":"2024-02-16","current":-68.677874,"twenty":-39.888941,"median":-31.961952,"eighty":-5.505043,"marketCap":91813733},{"date":"2024-02-23","current":-59.169936,"twenty":-40.466999,"median":-34.275268,"eighty":-5.692782,"marketCap":79102808},{"date":"2024-03-01","current":-63.372175,"twenty":-41.597229,"median":-35.401364,"eighty":-5.759273,"marketCap":84720676},{"date":"2024-03-08","current":-73.849585,"twenty":-41.945287,"median":-36.142899,"eighty":-5.808163,"marketCap":98727664},{"date":"2024-03-15","current":-76.245081,"twenty":-43.210183,"median":-36.501144,"eighty":-5.849231,"marketCap":101930142},{"date":"2024-03-22","current":-103.758666,"twenty":-50.901256,"median":-37.320992,"eighty":-6.027192,"marketCap":138712367},{"date":"2024-03-28","current":-90.558053,"twenty":-57.709789,"median":-37.373837,"eighty":-6.291199,"marketCap":121064797},{"date":"2024-04-05","current":-61.481111,"twenty":-59.566286,"median":-37.479952,"eighty":-6.48676,"marketCap":133529165},{"date":"2024-04-12","current":-71.595379,"twenty":-59.997513,"median":-38.212361,"eighty":-6.942417,"marketCap":155496070},{"date":"2024-04-19","current":-71.737433,"twenty":-62.930842,"median":-38.413768,"eighty":-7.153624,"marketCap":155804594},{"date":"2024-04-26","current":-94.969175,"twenty":-65.856384,"median":-38.647222,"eighty":-7.237715,"marketCap":206260987},{"date":"2024-05-03","current":-91.738931,"twenty":-67.584491,"median":-38.965567,"eighty":-7.396119,"marketCap":199245307},{"date":"2024-05-10","current":-90.826862,"twenty":-70.379394,"median":-39.220244,"eighty":-7.806798,"marketCap":197264409},{"date":"2024-05-17","current":-48.426621,"twenty":-71.185147,"median":-39.390029,"eighty":-8.309389,"marketCap":201061130},{"date":"2024-05-24","current":-37.632017,"twenty":-70.941929,"median":-39.252477,"eighty":-8.383702,"marketCap":156243317},{"date":"2024-05-31","current":-39.142864,"twenty":-70.600999,"median":-39.231253,"eighty":-8.399347,"marketCap":162516160},{"date":"2024-06-07","current":-38.288042,"twenty":-69.492975,"median":-39.142864,"eighty":-8.458016,"marketCap":158967051},{"date":"2024-06-14","current":-39.282021,"twenty":-68.840894,"median":-39.122984,"eighty":-8.473661,"marketCap":163093922},{"date":"2024-06-21","current":-42.542269,"twenty":-68.382795,"median":-39.092906,"eighty":-8.635976,"marketCap":176630057},{"date":"2024-06-28","current":-34.133213,"twenty":-68.186075,"median":-39.083225,"eighty":-8.741579,"marketCap":141716732},{"date":"2024-07-05","current":-31.54887,"twenty":-67.93606,"median":-38.965567,"eighty":-8.944963,"marketCap":130986869},{"date":"2024-07-12","current":-31.668147,"twenty":-66.717294,"median":-38.65716,"eighty":-9.034921,"marketCap":131482094},{"date":"2024-07-15","current":-31.707906,"twenty":-66.428229,"median":-38.645875,"eighty":-9.044699,"marketCap":131647168},{"date":"2024-08-02","current":-24.571142,"twenty":-66.410457,"median":-38.635937,"eighty":-9.075989,"marketCap":102016238},{"date":"2024-08-09","current":-22.543427,"twenty":-66.310958,"median":-38.456214,"eighty":-9.287195,"marketCap":93597422},{"date":"2024-08-16","current":-27.887378,"twenty":-66.13481,"median":-38.31907,"eighty":-9.647027,"marketCap":140643746},{"date":"2024-08-23","current":-25.694357,"twenty":-65.856384,"median":-38.201961,"eighty":-9.711562,"marketCap":129583733},{"date":"2024-08-30","current":-27.036355,"twenty":-65.492725,"median":-38.049488,"eighty":-9.848454,"marketCap":136351801},{"date":"2024-09-06","current":-24.27053,"twenty":-64.492663,"median":-37.878225,"eighty":-10.364736,"marketCap":122402979},{"date":"2024-09-13","current":-27.789183,"twenty":-63.372175,"median":-37.791053,"eighty":-10.687412,"marketCap":140148522},{"date":"2024-09-20","current":-28.591109,"twenty":-62.958476,"median":-37.555984,"eighty":-10.775414,"marketCap":144192855},{"date":"2024-09-27","current":-25.056089,"twenty":-62.820306,"median":-37.39506,"eighty":-10.956308,"marketCap":126364774},{"date":"2024-10-04","current":-21.291948,"twenty":-61.546921,"median":-37.320992,"eighty":-18.460659,"marketCap":107381170},{"date":"2024-10-11","current":-20.65368,"twenty":-61.481111,"median":-37.075389,"eighty":-19.851755,"marketCap":104162211},{"date":"2024-10-18","current":-22.993995,"twenty":-60.002788,"median":-36.396302,"eighty":-20.65368,"marketCap":115965061},{"date":"2024-10-25","current":-20.571851,"twenty":-59.976413,"median":-36.164122,"eighty":-20.2609,"marketCap":103749524},{"date":"2024-10-31","current":-23.043092,"twenty":-59.793721,"median":-35.612321,"eighty":-20.509661,"marketCap":116212673},{"date":"2024-11-08","current":-20.506388,"twenty":-59.656441,"median":-34.614837,"eighty":-20.378734,"marketCap":103419374},{"date":"2024-11-15","current":-7.544112,"twenty":-59.364528,"median":-34.033815,"eighty":-19.864847,"marketCap":90130851},{"date":"2024-11-22","current":-6.618369,"twenty":-59.195404,"median":-32.598152,"eighty":-10.920129,"marketCap":79070838},{"date":"2024-11-29","current":-7.461209,"twenty":-58.838839,"median":-31.688026,"eighty":-10.106595,"marketCap":89140402},{"date":"2024-12-06","current":-6.715088,"twenty":-58.392606,"median":-31.54887,"eighty":-9.138568,"marketCap":80226362},{"date":"2024-12-13","current":-1.333346,"twenty":-58.187646,"median":-30.753634,"eighty":-8.46975,"marketCap":15929720},{"date":"2024-12-20","current":-1.540602,"twenty":-56.826908,"median":-30.356096,"eighty":-8.266296,"marketCap":18405842},{"date":"2024-12-27","current":-1.658046,"twenty":-55.349782,"median":-29.88401,"eighty":-7.711877,"marketCap":19808978},{"date":"2025-01-03","current":-1.540602,"twenty":-54.314096,"median":-29.245398,"eighty":-7.461209,"marketCap":18405842},{"date":"2025-01-10","current":-1.506059,"twenty":-53.736829,"median":-28.656572,"eighty":-7.247045,"marketCap":17993155},{"date":"2025-01-17","current":-1.457699,"twenty":-49.142285,"median":-28.610519,"eighty":-7.137979,"marketCap":17415393},{"date":"2025-01-24","current":-1.568236,"twenty":-48.569754,"median":-27.928293,"eighty":-6.857839,"marketCap":18735992},{"date":"2025-01-31","current":-1.554419,"twenty":-47.997222,"median":-27.789183,"eighty":-6.629423,"marketCap":18570917},{"date":"2025-02-07","current":-1.540602,"twenty":-46.896292,"median":-27.420952,"eighty":-6.014862,"marketCap":18405842},{"date":"2025-02-14","current":-1.512967,"twenty":-44.339166,"median":-26.825968,"eighty":-5.724072,"marketCap":18075692},{"date":"2025-02-21","current":-1.606232,"twenty":-43.761983,"median":-26.659941,"eighty":-5.262548,"marketCap":19189947},{"date":"2025-02-28","current":-1.506059,"twenty":-43.736515,"median":-26.497871,"eighty":-5.163594,"marketCap":17993155},{"date":"2025-03-07","current":-1.485333,"twenty":-43.013176,"median":-26.414453,"eighty":-5.041564,"marketCap":17745543},{"date":"2025-03-14","current":-4.000037,"twenty":-42.484599,"median":-25.784369,"eighty":-4.787335,"marketCap":47789160},{"date":"2025-03-21","current":-6.175515,"twenty":-42.267878,"median":-25.530698,"eighty":-4.787335,"marketCap":100603431},{"date":"2025-03-28","current":-4.54082,"twenty":-42.072626,"median":-25.219748,"eighty":-4.727048,"marketCap":73973111},{"date":"2025-04-04","current":-6.004566,"twenty":-41.996223,"median":-24.761504,"eighty":-4.759999,"marketCap":97818561},{"date":"2025-04-11","current":-4.524793,"twenty":-41.928309,"median":-24.40964,"eighty":-4.724538,"marketCap":73712029},{"date":"2025-04-17","current":-5.069692,"twenty":-41.877374,"median":-24.063652,"eighty":-4.723843,"marketCap":82588803},{"date":"2025-04-25","current":-4.701084,"twenty":-41.783992,"median":-23.534067,"eighty":-4.709632,"marketCap":76583927},{"date":"2025-05-02","current":-5.641301,"twenty":-41.648164,"median":-23.444055,"eighty":-4.709632,"marketCap":91900712},{"date":"2025-05-09","current":-4.754506,"twenty":-41.597229,"median":-22.993995,"eighty":-4.723843,"marketCap":77454199},{"date":"2025-05-16","current":-4.027311,"twenty":-41.563272,"median":-22.735979,"eighty":-4.636974,"marketCap":75191492}],"updateTime":1747582637453}}}